NCT06466837 Just-In-Time Adaptive Interventions for Diabetic Patients
| NCT ID | NCT06466837 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The Hong Kong Polytechnic University |
| Condition | Diabetes |
| Study Type | INTERVENTIONAL |
| Enrollment | 184 participants |
| Start Date | 2024-09-01 |
| Primary Completion | 2026-02-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 184 participants in total. It began in 2024-09-01 with a primary completion date of 2026-02-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The addition of proactive nurse consultations was useful to older adults with diabetes mellitus in facilitating their chronic disease self-management. However, the service is time and resource-intensive. With the support of advanced technology, mhealth App seems to be a convenient way to support patients in managing diabetes.
Eligibility Criteria
Inclusion Criteria: * With a confirmed DM diagnosis for one year or more than one year * Using governmental mhealth App * Living in an area with Internet coverage Exclusion Criteria: * Already engaged in other mHealth programmes * Physical and cognitive limitations
Contact & Investigator
Arkers Wong, PhD
PRINCIPAL INVESTIGATOR
The Hong Kong Polytechnic University
Frequently Asked Questions
Who can join the NCT06466837 clinical trial?
This trial is open to participants of all sexes, aged 60 Years or older, studying Diabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06466837 currently recruiting?
Yes, NCT06466837 is actively recruiting participants. Contact the research team at arkers.wong@polyu.edu.hk for enrollment information.
Where is the NCT06466837 trial being conducted?
This trial is being conducted at Hong Kong, Hong Kong.
Who is sponsoring the NCT06466837 clinical trial?
NCT06466837 is sponsored by The Hong Kong Polytechnic University. The principal investigator is Arkers Wong, PhD at The Hong Kong Polytechnic University. The trial plans to enroll 184 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.